vs
Side-by-side financial comparison of MFA FINANCIAL, INC. (MFA) and RxSight, Inc. (RXST). Click either name above to swap in a different company.
MFA FINANCIAL, INC. is the larger business by last-quarter revenue ($55.5M vs $32.6M, roughly 1.7× RxSight, Inc.). On growth, MFA FINANCIAL, INC. posted the faster year-over-year revenue change (9.2% vs -18.9%). Over the past eight quarters, MFA FINANCIAL, INC.'s revenue compounded faster (7.7% CAGR vs 5.1%).
MFA Financial, Inc. is a U.S.-headquartered real estate investment trust (REIT) specializing in investing in and managing residential and commercial mortgage-backed securities, mortgage loans, and other real estate-related financial assets. It caters primarily to institutional and individual investors across the U.S., focusing on delivering stable risk-adjusted returns via rigorous asset screening and risk management frameworks.
RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.
MFA vs RXST — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $55.5M | $32.6M |
| Net Profit | — | $-9.2M |
| Gross Margin | — | 77.5% |
| Operating Margin | 97.9% | -34.8% |
| Net Margin | — | -28.1% |
| Revenue YoY | 9.2% | -18.9% |
| Net Profit YoY | — | -54.1% |
| EPS (diluted) | $0.43 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $55.5M | $32.6M | ||
| Q3 25 | $56.8M | $30.3M | ||
| Q2 25 | $61.3M | $33.6M | ||
| Q1 25 | $57.5M | $37.9M | ||
| Q4 24 | $50.8M | $40.2M | ||
| Q3 24 | $50.6M | $35.3M | ||
| Q2 24 | $53.5M | $34.9M | ||
| Q1 24 | $47.8M | $29.5M |
| Q4 25 | — | $-9.2M | ||
| Q3 25 | $48.1M | $-9.8M | ||
| Q2 25 | $33.2M | $-11.8M | ||
| Q1 25 | $41.2M | $-8.2M | ||
| Q4 24 | — | $-5.9M | ||
| Q3 24 | $48.2M | $-6.3M | ||
| Q2 24 | $41.9M | $-6.1M | ||
| Q1 24 | $23.2M | $-9.1M |
| Q4 25 | — | 77.5% | ||
| Q3 25 | — | 79.9% | ||
| Q2 25 | — | 74.9% | ||
| Q1 25 | — | 74.8% | ||
| Q4 24 | — | 71.6% | ||
| Q3 24 | — | 71.4% | ||
| Q2 24 | — | 69.5% | ||
| Q1 24 | — | 70.1% |
| Q4 25 | 97.9% | -34.8% | ||
| Q3 25 | 84.5% | -40.1% | ||
| Q2 25 | 54.5% | -41.6% | ||
| Q1 25 | 70.0% | -28.2% | ||
| Q4 24 | 6.8% | -21.5% | ||
| Q3 24 | 98.2% | -26.1% | ||
| Q2 24 | 79.1% | -23.9% | ||
| Q1 24 | 50.7% | -36.2% |
| Q4 25 | — | -28.1% | ||
| Q3 25 | 84.7% | -32.4% | ||
| Q2 25 | 54.2% | -35.0% | ||
| Q1 25 | 71.6% | -21.6% | ||
| Q4 24 | — | -14.8% | ||
| Q3 24 | 95.2% | -17.9% | ||
| Q2 24 | 78.4% | -17.4% | ||
| Q1 24 | 48.5% | -30.8% |
| Q4 25 | $0.43 | $-0.22 | ||
| Q3 25 | $0.35 | $-0.24 | ||
| Q2 25 | $0.21 | $-0.29 | ||
| Q1 25 | $0.31 | $-0.20 | ||
| Q4 24 | $-0.01 | $-0.14 | ||
| Q3 24 | $0.37 | $-0.16 | ||
| Q2 24 | $0.32 | $-0.16 | ||
| Q1 24 | $0.14 | $-0.25 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $213.2M | $228.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.8B | $275.7M |
| Total Assets | $13.0B | $311.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $213.2M | $228.1M | ||
| Q3 25 | $305.2M | $227.5M | ||
| Q2 25 | $275.7M | $227.5M | ||
| Q1 25 | $253.7M | $229.3M | ||
| Q4 24 | $338.9M | $237.2M | ||
| Q3 24 | $305.6M | $237.1M | ||
| Q2 24 | $289.4M | $233.3M | ||
| Q1 24 | $306.3M | $125.4M |
| Q4 25 | $1.8B | $275.7M | ||
| Q3 25 | $1.8B | $276.0M | ||
| Q2 25 | $1.8B | $278.0M | ||
| Q1 25 | $1.8B | $279.3M | ||
| Q4 24 | $1.8B | $281.2M | ||
| Q3 24 | $1.9B | $277.3M | ||
| Q2 24 | $1.9B | $275.2M | ||
| Q1 24 | $1.9B | $163.9M |
| Q4 25 | $13.0B | $311.8M | ||
| Q3 25 | $12.1B | $308.5M | ||
| Q2 25 | $11.7B | $309.0M | ||
| Q1 25 | $11.5B | $313.0M | ||
| Q4 24 | $11.4B | $318.6M | ||
| Q3 24 | $11.2B | $310.5M | ||
| Q2 24 | $11.1B | $305.5M | ||
| Q1 24 | $10.9B | $183.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $76.2M | $-1.1M |
| Free Cash FlowOCF − Capex | — | $-2.3M |
| FCF MarginFCF / Revenue | — | -6.9% |
| Capex IntensityCapex / Revenue | — | 3.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-19.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $76.2M | $-1.1M | ||
| Q3 25 | $14.7M | $-1.2M | ||
| Q2 25 | $38.5M | $-4.4M | ||
| Q1 25 | $-14.6M | $-8.8M | ||
| Q4 24 | $200.1M | $-4.3M | ||
| Q3 24 | $-11.3M | $650.0K | ||
| Q2 24 | $46.5M | $-4.0M | ||
| Q1 24 | $53.5M | $-9.3M |
| Q4 25 | — | $-2.3M | ||
| Q3 25 | — | $-1.8M | ||
| Q2 25 | — | $-5.9M | ||
| Q1 25 | — | $-9.4M | ||
| Q4 24 | — | $-5.1M | ||
| Q3 24 | — | $-453.0K | ||
| Q2 24 | — | $-5.5M | ||
| Q1 24 | — | $-11.3M |
| Q4 25 | — | -6.9% | ||
| Q3 25 | — | -5.8% | ||
| Q2 25 | — | -17.6% | ||
| Q1 25 | — | -24.8% | ||
| Q4 24 | — | -12.7% | ||
| Q3 24 | — | -1.3% | ||
| Q2 24 | — | -15.9% | ||
| Q1 24 | — | -38.2% |
| Q4 25 | — | 3.5% | ||
| Q3 25 | — | 1.9% | ||
| Q2 25 | — | 4.6% | ||
| Q1 25 | — | 1.5% | ||
| Q4 24 | — | 2.1% | ||
| Q3 24 | — | 3.1% | ||
| Q2 24 | — | 4.4% | ||
| Q1 24 | — | 6.7% |
| Q4 25 | — | — | ||
| Q3 25 | 0.31× | — | ||
| Q2 25 | 1.16× | — | ||
| Q1 25 | -0.35× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.23× | — | ||
| Q2 24 | 1.11× | — | ||
| Q1 24 | 2.30× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MFA
Segment breakdown not available.
RXST
| Rxlal | $28.2M | 86% |
| LDD | $3.0M | 9% |
| Service Warranty Service Contracts And Accessories | $1.5M | 4% |
